Trump threatens 200% drug tariffs

President Donald Trump Tuesday threatened to apply up to 200% of the pharmaceuticals brought to the United States.

“There will be very high degree of tariff as 200%,” Trump said at the cabinet session.

However, he said they would not immediately take effect on these takeoff and saying that he would “about a year, and a half”.

“We will give them a certain amount of time to get their actions to get together,” Trump said, probably referring to drugs that bring the leaders to the United States

Details on pharmaceutical tariffs “Fundamentally”, “Trading Secretary Howard Lutnick will tell CNBC after the meeting of the Cabinet of Ministers.

“These studies end with pharmaceutical and semiconductors, so the President will then determine its policy and I will wait to decide how it will do.”

The president has repeatedly threatened and then changed the course on tariff proposals, so there is no guarantee that it will determine 200% of these drug tariffs. Pharmaceutical reserves were mainly unchanged after Trump’s comments.

David Ridisinger analyst Leerink partners on Tuesday, David Rideasinger believed that the announcement is positive for the industry, because tariffs will not be implemented immediately …

This has been the most important comment since April since April since April, which has launched a so-called 232 investigation about these products. This legal authority allows the trade secretary to investigate the impact of imports to national security.

The planned tariffs will receive a long-awaited blow to pharmaceutical companies retreated and warns that collectors can draw expenses, prevented investment In the United States and the drug supply chain, the patients are at risk. The industry is already navigating Fallout from Trump Drug prices policyThe leading presenters threaten both sub-lines and the ability to invest in research and development.

Trump said that the tariffs will encourage production operations to the United States Eli lilli, Johnson & Johnson, Abbvie Others put more money in the United States after the production of domestic drug production in the last few decades.

The largest lobby group of industry in the United States, Phrma, repeated the previous statement returned to the pharmaceutical tariffs.

“Alex Schriver, the main vice-president of any dollars, American production or future treatment and patients spent on the tariffs, is called the Alex Schriver, a statement.

“Industry President Trump has raised American production and has recently announced that hundreds of dollars in the United States, but tariffs for these efforts,” he said. “Drugs were released from historous tariffs because they can increase the costs and cause shortcomings.”